Valeant CEO: More efficient, available health care needed
CHICAGO — Making health care more efficient and access to that health care more available as the population ages has become an important factor for the companies involved in pharmaceuticals and technology, Joseph Papa, chairman and CEO of Valeant Pharmaceuticals, said during a press briefing here.
In discussing Valeant and Bausch + Lomb’s strategies for addressing these trends, Papa said that consumption of eye care drugs and treatments is 7.8 times greater in persons older than 60 years of age than in those who are younger.
“As society gets older and people live longer, you’re clearly going to face the question and have more utilization of pharmaceutical products in the future,” Papa said. “We’ve got to be out there and try to get in front of that with demands and anticipation of the future.”
In order to do so, the company is ramping up its focus on efficiency by focusing on innovation and finding ways to make products more affordable for patients, as well as focusing on making sure patients can access products when they need them, he said.
“Innovation is the lifeblood of any company in health care,” Papa said. – by Rebecca L. Forand